Clinical & Epidemiological Insights
Dynamic statistical patterns discovered across longitudinal oncology records
Every insight displays its underlying statistical cohort, exact mathematical calculation, and empirical sample size. Click Explore Cohort on any card to isolate and inspect the matching patients in the interactive cohort builder.
"Head & neck malignancies account for 28.6% of all synthetic oncology registry cases"
Clinical Interpretation: Reflects the high regional epidemiological prevalence of oral cavity and upper aerodigestive tract cancers in Western India associated with smokeless tobacco consumption patterns.
"Locally advanced Stage III cases represent the single largest group (60.6%) among head & neck patients"
Clinical Interpretation: Delayed presentation at advanced stages (T3/T4 or N+) highlights the critical necessity of aggressive multimodal intervention and early community screening.
"52.4% of tongue cancer patients receive combined multimodal therapy (Surgery + Adjuvant CRT)"
Clinical Interpretation: Adjuvant chemoradiotherapy following primary surgical resection with neck dissection remains the standard of care for high-risk pathological features (positive nodes, perineural invasion).
"24.2% of registered patients have achieved 5+ years of active longitudinal surveillance"
Clinical Interpretation: Longitudinal surveillance allows robust real-world survival benchmarking and monitoring for late radiation toxicities or secondary metachronous malignancies.
"82% of all documented recurrences occurred within the first 24 months post-diagnosis"
Clinical Interpretation: Demonstrates that intensive 3-monthly surveillance imaging and clinical evaluations are highest-yield during the first 2 post-treatment years.